PolitiKit

Canadian Environment Protection Act and its regulations for Volatile Organic Compounds.

Chemicals Management Plan regarding the review of existing, and new substances, which may be used in the CASE sector.

Regulatory harmonization and reduction of trade irritants with major trading partners

Discussion related to pre-budget and budget and measures that would make members more competitive.

Regulatory Modernization and Red Tape Reduction

Chemicals Management Plan regarding the review of existing, and new substances, which may be used in the CASE sector.

Regulatory Modernization and Red Tape Reduction

Government Cost Recovery and User Fee Programs with respect to the Pesticides Regulatory Directorate and/or Chemical Management Plan.

Regulatory harmonization and reduction of trade irritants with major trading partners

Legislation, regulations and policy directives that would increase the competitiveness of domestic manufacturing.

Importance of CUSMA to the coatings sector.

Pest Control Products Act and the regulation of biocides.

Regulations and defence procurement

Discussion related to pre-budget and budget and measures that would make members more competitive.

Cabinet Directive on Regulation regarding the expectations and requirements in the development, management and review of federal regulations.

Chemicals Management Plan regarding the review of existing, and new substances, which may be used in the CASE sector.

Legislation, regulations and policy directives that would increase the competitiveness of domestic manufacturing.

Government Cost Recovery and User Fee Programs with respect to the Pesticides Regulatory Directorate and/or Chemical Management Plan.

Regulations and defence procurement

Pest Control Products Act and the regulation of biocides.

Regulatory harmonization and reduction of trade irritants with major trading partners

Discussion related to pre-budget and budget and measures that would make members more competitive.

Chemicals Management Plan regarding the review of existing, and new substances, which may be used in the CASE sector.

Pest Control Products Act and the regulation of biocides.

Regulatory Modernization and Red Tape Reduction

Legislation, regulations and policy directives that would increase the competitiveness of domestic manufacturing.

Discussion related to pre-budget and budget and measures that would make members more competitive.

Regulatory Modernization and Red Tape Reduction

Legislation, regulations and policy directives that would increase the competitiveness of domestic manufacturing.

Pest Control Products Act and the regulation of biocides.

Discussion related to pre-budget and budget and measures that would make members more competitive.

Regulatory Modernization and Red Tape Reduction

Regulatory harmonization and reduction of trade irritants with major trading partners

Chemicals Management Plan regarding the review of existing, and new substances, which may be used in the CASE sector.

Discussion related to pre-budget and budget and measures that would make members more competitive.

Government Cost Recovery and User Fee Programs with respect to the Pest Management Regulatory Agency.

Improve access to mental health and psychological services with respect to all Canadians

Clinical decision support: Support the national integration of Clinical Decision Support (CDS) systems into electronic medical records (EMRs) to ensure that patients receive the right test at the right time.

Capital equipment (CT and MRI): Guide a dedicated investment of $2 billion over three years for radiology equipment to improve access to modern medical imaging equipment. Streamline the process for equipment installation and reduce the substantial associated labour costs.

Artificial Intelligence: Demonstrate leadership in AI by providing financial support for the Health Artificial Intelligence Validation Network (HAIVN) to improve the evaluation and regulation of AI in Canada as part of Health Canada’s Medical Devices Directorate regulatory process, for the purpose of improved healthcare, economic development and innovation in Canada.

Health human resources: Develop a strategy to recruit and retain radiologists, medical radiation technologists, and sonographers as part of a national approach to health human resources to reduce backlogs and improve health services.

Clinical decision support: Support the national integration of Clinical Decision Support (CDS) systems into electronic medical records (EMRs) to ensure that patients receive the right test at the right time.

Artificial Intelligence: Demonstrate leadership in AI by providing financial support for the Health Artificial Intelligence Validation Network (HAIVN) to improve the evaluation and regulation of AI in Canada as part of Health Canada’s Medical Devices Directorate regulatory process, for the purpose of improved healthcare, economic development and innovation in Canada.

Health human resources: Develop a strategy to recruit and retain radiologists, medical radiation technologists, and sonographers as part of a national approach to health human resources to reduce backlogs and improve health services.

Capital equipment (CT and MRI): Guide a dedicated investment of $2 billion over three years for radiology equipment to improve access to modern medical imaging equipment. Streamline the process for equipment installation and reduce the substantial associated labour costs.

Artificial Intelligence: Demonstrate leadership in AI by providing financial support for the Health Artificial Intelligence Validation Network (HAIVN) to improve the evaluation and regulation of AI in Canada as part of Health Canada’s Medical Devices Directorate regulatory process, for the purpose of improved healthcare, economic development and innovation in Canada.

Capital equipment (CT and MRI): Guide a dedicated investment of $2 billion over three years for radiology equipment to improve access to modern medical imaging equipment. Streamline the process for equipment installation and reduce the substantial associated labour costs.

Clinical decision support: Support the national integration of Clinical Decision Support (CDS) systems into electronic medical records (EMRs) to ensure that patients receive the right test at the right time.

Capital equipment (CT and MRI): Guide a dedicated investment of $2 billion over three years for radiology equipment to improve access to modern medical imaging equipment. Streamline the process for equipment installation and reduce the substantial associated labour costs.

Artificial Intelligence: Demonstrate leadership in AI by providing financial support for the Health Artificial Intelligence Validation Network (HAIVN) to improve the evaluation and regulation of AI in Canada as part of Health Canada’s Medical Devices Directorate regulatory process, for the purpose of improved healthcare, economic development and innovation in Canada.

Health human resources: Develop a strategy to recruit and retain radiologists, medical radiation technologists, and sonographers as part of a national approach to health human resources to reduce backlogs and improve health services.

Capital equipment (CT and MRI): Guide a dedicated investment of $2 billion over three years for radiology equipment to improve access to modern medical imaging equipment. Streamline the process for equipment installation and reduce the substantial associated labour costs.

Artificial Intelligence: Demonstrate leadership in AI by providing financial support for the Health Artificial Intelligence Validation Network (HAIVN) to improve the evaluation and regulation of AI in Canada as part of Health Canada’s Medical Devices Directorate regulatory process, for the purpose of improved healthcare, economic development and innovation in Canada.

Health human resources: Develop a strategy to recruit and retain radiologists, medical radiation technologists, and sonographers as part of a national approach to health human resources to reduce backlogs and improve health services.

Clinical decision support: Support the national integration of Clinical Decision Support (CDS) systems into electronic medical records (EMRs) to ensure that patients receive the right test at the right time.

Artificial Intelligence: Demonstrate leadership in AI by providing financial support for the Health Artificial Intelligence Validation Network (HAIVN) to improve the evaluation and regulation of AI in Canada as part of Health Canada’s Medical Devices Directorate regulatory process, for the purpose of improved healthcare, economic development and innovation in Canada.

Health human resources: Develop a strategy to recruit and retain radiologists, medical radiation technologists, and sonographers as part of a national approach to health human resources to reduce backlogs and improve health services.

Clinical decision support: Support the national integration of Clinical Decision Support (CDS) systems into electronic medical records (EMRs) to ensure that patients receive the right test at the right time.

Artificial Intelligence: Demonstrate leadership in AI by providing financial support for the Health Artificial Intelligence Validation Network (HAIVN) to improve the evaluation and regulation of AI in Canada as part of Health Canada’s Medical Devices Directorate regulatory process, for the purpose of improved healthcare, economic development and innovation in Canada.

Capital equipment (CT and MRI): Guide a dedicated investment of $2 billion over three years for radiology equipment to improve access to modern medical imaging equipment. Streamline the process for equipment installation and reduce the substantial associated labour costs.

Clinical decision support: Support the national integration of Clinical Decision Support (CDS) systems into electronic medical records (EMRs) to ensure that patients receive the right test at the right time.

Artificial Intelligence: Demonstrate leadership in AI by providing financial support for the Health Artificial Intelligence Validation Network (HAIVN) to improve the evaluation and regulation of AI in Canada as part of Health Canada’s Medical Devices Directorate regulatory process, for the purpose of improved healthcare, economic development and innovation in Canada.

Artificial Intelligence: Demonstrate leadership in AI by providing financial support for the Health Artificial Intelligence Validation Network (HAIVN) to improve the evaluation and regulation of AI in Canada as part of Health Canada’s Medical Devices Directorate regulatory process, for the purpose of improved healthcare, economic development and innovation in Canada.

Health human resources: Develop a strategy to recruit and retain radiologists, medical radiation technologists, and sonographers as part of a national approach to health human resources to reduce backlogs and improve health services.

Capital equipment (CT and MRI): Guide a dedicated investment of $2 billion over three years for radiology equipment to improve access to modern medical imaging equipment. Streamline the process for equipment installation and reduce the substantial associated labour costs.

Clinical decision support: Support the national integration of Clinical Decision Support (CDS) systems into electronic medical records (EMRs) to ensure that patients receive the right test at the right time.

Capital equipment (CT and MRI): Guide a dedicated investment of $2 billion over three years for radiology equipment to improve access to modern medical imaging equipment. Streamline the process for equipment installation and reduce the substantial associated labour costs.

Artificial Intelligence: Demonstrate leadership in AI by providing financial support for the Health Artificial Intelligence Validation Network (HAIVN) to improve the evaluation and regulation of AI in Canada as part of Health Canada’s Medical Devices Directorate regulatory process, for the purpose of improved healthcare, economic development and innovation in Canada.

Clinical decision support: Support the national integration of Clinical Decision Support (CDS) systems into electronic medical records (EMRs) to ensure that patients receive the right test at the right time.

Health human resources: Develop a strategy to recruit and retain radiologists, medical radiation technologists, and sonographers as part of a national approach to health human resources to reduce backlogs and improve health services.

Artificial Intelligence: Demonstrate leadership in AI by providing financial support for the Health Artificial Intelligence Validation Network (HAIVN) to improve the evaluation and regulation of AI in Canada as part of Health Canada’s Medical Devices Directorate regulatory process, for the purpose of improved healthcare, economic development and innovation in Canada.

Clinical decision support: Support the national integration of Clinical Decision Support (CDS) systems into electronic medical records (EMRs) to ensure that patients receive the right test at the right time.

Capital equipment (CT and MRI): Guide a dedicated investment of $2 billion over three years for radiology equipment to improve access to modern medical imaging equipment. Streamline the process for equipment installation and reduce the substantial associated labour costs.

Artificial Intelligence: Demonstrate leadership in AI by providing financial support for the Health Artificial Intelligence Validation Network (HAIVN) to improve the evaluation and regulation of AI in Canada as part of Health Canada’s Medical Devices Directorate regulatory process, for the purpose of improved healthcare, economic development and innovation in Canada.

The Building Industry and Land Development Association is seeking reforms to Government Imposes Taxes, Fees and Charges and its associated policy framework to improve the feasibility of housing development projects, including measures related to development charges, infrastructure financing, foreign buyers, mortgage interest and improve the tax structure's competitiveness for housing and infrastructure investment.

The Building Industry and Land Development Association is seeking relief from HST in the form of enhanced rebates and a sustainable model for future indexing.

Oppose amendments to the Food and Drugs Act to extend powers brought in under the 'ProtectCanadians from Unsafe Drugs Act (Vanessa’s Law)' to regulate natural health products.

Natural Health Products Regulations – advocacy for fair and consistent interpretation by the regulator. Ensuring plain Language Labeling under the self-care products framework is fair. Advocacy against allowing personal importation of natural health products.